Results 181 to 190 of about 194,403 (293)

Neurocardiac crosstalk in inherited cardiac arrhythmias and cardiomyopathy

The Journal of Physiology, EarlyView.
Abstract figure legend In inherited cardiac arrhythmias and cardiomyopathy, arrhythmias are typically triggered by autonomic nervous system activity. Genetic mutations linked to these conditions cause pro‐arrhythmic alterations in both cardiomyocytes and neurons, with their pathophysiological crosstalk likely amplifying the manifestation of the disease.
Carol Ann Remme, Molly O'Reilly
wiley   +1 more source

Spiked Helmet Sign in the Early Post-Heart Transplantation Period: A Dramatic STEMI Mimic in a Structurally Normal Donor Heart. [PDF]

Ann Noninvasive Electrocardiol
A 36‐year‐old woman developed Spiked Helmet Sign after heart transplantation complicated by subarachnoid hemorrhage and septic shock. Although the ECG changes resolved, she died from infectious complications, highlighting SHS as a marker of critical illness and poor prognosis.
Lima DRM, Segundo GSD, Targueta GP, Teixeira RTB, Meira AT, Athayde GAT.   +5 more
europepmc   +2 more sources

The role of extracellular vesicles in cell–cell crosstalk in cardiotoxicity

The Journal of Physiology, EarlyView.
Abstract figure legend Administration of a pharmacological agent can result in off‐target cardiotoxicity which can be driven by cell–cell crosstalk between healthy and dysfunctional cardiac cells. Extracellular vesicles (EVs) are lipid bilayer structures that can move biological cargo between cells, facilitating cell–cell crosstalk.
Gabriella Bachynskyj‐Bilas, Debbie J. Otto, Daniel Stratton, Katja Rietdorf, Daniel M. Johnson, Calum J. McMullen   +5 more
wiley   +1 more source

Caenorhabditis elegans as an in vivo model system for human inherited primary arrhythmia syndromes

The Journal of Physiology, EarlyView.
Abstract figure legend Most genes involved in inherited primary arrhythmia syndromes (IPAS) are conserved in Caenorhabditis elegans, where genetic manipulation enables functional characterization of variants, identification of regulatory proteins, and in vivo drug testing.
Antoine Delinière, Thomas Boulin, Maëlle Jospin, Alexandre Janin, Gilles Millat, Philippe Chevalier, Olga Andrini   +6 more
wiley   +1 more source

Translating cardiovascular ion channel and Ca2+ signalling mechanisms into therapeutic insights

The Journal of Physiology, EarlyView.
Abstract figure legend This white paper integrates mechanistic discoveries across ion channel biology, Ca2+ signalling and multiscale cardiovascular physiology to highlight new opportunities for accelerating research and guiding next‐generation therapies. Printed with permission from ®Anita Impagliazzo Medical Illustration. [Correction added on 2 March
Silvia Marchianò, Miguel Martín‐Aragón Baudel, Charlotte E. R. Smith, Gonzalo Hernandez Hernandez, Donald M. Bers, Patrick M. Boyle, Dobromir Dobrev, Shanna Hamilton, Osama F. Harraz, Na Li, Thomas A. Longden, William E. Louch, Madeline Nieves‐Cintron, Matthew A. Nystoriak, Walter Lee Murfee, Przemysław B. Radwański, Swapnil K. Sonkusare, Manuel F. Navedo, Eleonora Grandi   +18 more
wiley   +1 more source

A retrospective study of mode of delivery in patients with hypertrophic vs other forms of cardiomyopathy. [PDF]

Am J Obstet Gynecol MFM
Meng ML, Acuff H, Champion C, Peclat T, Fuller M, Arendt KW, Lindley KJ, Federspiel J, Boggess K, Quist-Nelson J.   +9 more
europepmc   +1 more source

Long‐Term Use of Rezafungin: A Case Report and Insights Into Real‐World Access

Transplant Infectious Disease, EarlyView.
Jian Mei Li, Jacqueline E. Clark, Tiffany Wu   +2 more
wiley   +1 more source

Right Ventricular Dysfunction and Ventriculo‐Arterial Uncoupling in Heart Failure With Preserved Ejection Fraction: A Phenotype‐Specific Review of Mechanisms, Diagnosis, and Therapeutic Strategies

Clinical Cardiology, Volume 49, Issue 11, November 2026.
Right ventricular dysfunction affects 19%–33% of patients With heart failure With preserved ejection fraction and is associated With exercise intolerance, hospitalization, and mortality. Assessing right ventricular function and its coupling with the pulmonary circulation may improve risk stratification and support management tailored to distinct ...
Amarelle Chamoun, Talha Farooq, Suhayya Batool, Sadia Tameez‐ud—din, Muhammad Yousaf, Preet Memon, Mohsin Ali, Arun Kumar Maloth, F. N. U. Sawaira, Muhammad Taimur Khan, Mohammad Eisa Ali, Mansoor Khalid, Maleeha Pandit, Kamil Ahmad Kamil   +13 more
wiley   +1 more source

Temporal evolution of clinical event risk after primary-prevention ICD implantation: Chagas vs. non-Chagas dilated cardiomyopathy. [PDF]

Front Cardiovasc Med
Guzmán JP, Diaz Uberti P, Rosello C, Capobianco M, Piazza V, Di Tommaso F, Zubiri J, Toscano F.   +7 more
europepmc   +1 more source

Timing of Cardiac Contractility Modulation Therapy Implementation

Clinical Cardiology, Volume 49, Issue 11, November 2026.
In this retrospective registry analysis, cardiac contractility modulation (CCM) improved functional status and left ventricular ejection fraction whether implanted early or later. Implantation within 12 months after CCM‐eligible heart failure diagnosis might be associated with better survival, greater ejection‐fraction improvement, and fewer heart ...
Goekhan Yuecel, Gamze Yildirim, Kristin Schreiner, Svetlana Hetjens, Konstantinos Giannakopoulos, Abbass Kodeih, Mostafa Khalil, Babak Yazdani, Faeq Husain‐Syed, Daniel Duerschmied, William T. Abraham, Ibrahim Akin, Jürgen Kuschyk   +12 more
wiley   +1 more source